{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:02:12Z","timestamp":1790996532351,"version":"4.1.0"},"publisher-location":"Singapore","reference-count":100,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811065828","type":"print"},{"value":"9789811065835","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-981-10-6583-5_10","type":"book-chapter","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T12:55:48Z","timestamp":1510836948000},"page":"149-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["DJ-1 as a Biomarker of Parkinson\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Yoshiro","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,17]]},"reference":[{"key":"10_CR1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neulet.2010.08.007","volume":"483","author":"YO Akazawa","year":"2010","unstructured":"Akazawa YO, Saito Y, Hamakubo T, Masuo Y, Yoshida Y, Nishio K et al (2010) Elevation of oxidized DJ-1 in the brain and erythrocytes of Parkinson disease model animals. Neurosci Lett 483:201\u2013205","journal-title":"Neurosci Lett"},{"issue":"7","key":"10_CR2","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/nrn1434","volume":"10","author":"JK Andersen","year":"2004","unstructured":"Andersen JK (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10(7):S18\u2013S25","journal-title":"Nat Med"},{"key":"10_CR3","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/683920","volume":"2013","author":"H Ariga","year":"2013","unstructured":"Ariga H, Takahashi-Niki K, Kato I, Maita H, Niki T, Iguchi-Ariga SM (2013) Neuroprotective function of DJ-1 in Parkinson\u2019s disease. Oxidative Med Cell Longev 2013:683920","journal-title":"Oxidative Med Cell Longev"},{"key":"10_CR4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/brain\/awh054","volume":"127","author":"R Bandopadhyay","year":"2004","unstructured":"Bandopadhyay R, Kingsbury AE, Cookson MR, Reid AR, Evans IM, Hope AD et al (2004) The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson\u2019s disease. Brain 127:420\u2013430","journal-title":"Brain"},{"key":"10_CR5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-6-8","volume":"6","author":"FP Bellinger","year":"2011","unstructured":"Bellinger FP, Bellinger MT, Seale LA, Takemoto AS, Raman AV, Miki T et al (2011) Glutathione peroxidase 4 is associated with Neuromelanin in Substantia Nigra and dystrophic axons in putamen of Parkinson\u2019s brain. Mol Neurodegener 6:8","journal-title":"Mol Neurodegener"},{"key":"10_CR6","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1074\/jbc.M806599200","volume":"284","author":"J Blackinton","year":"2009","unstructured":"Blackinton J, Lakshminarasimhan M, Thomas KJ, Ahmad R, Greggio E, Raza AS et al (2009) Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1. J Biol Chem 284:6476\u20136485","journal-title":"J Biol Chem"},{"key":"10_CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","volume":"65","author":"D Blum","year":"2001","unstructured":"Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R et al (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson\u2019s disease. Prog Neurobiol 65:135\u2013172","journal-title":"Prog Neurobiol"},{"issue":"Suppl 1","key":"10_CR8","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S1353-8020(11)70004-9","volume":"18","author":"V Bonifati","year":"2012","unstructured":"Bonifati V (2012) Autosomal recessive parkinsonism. Parkinsonism Relat Disord 18(Suppl 1):S4\u2013S6","journal-title":"Parkinsonism Relat Disord"},{"key":"10_CR9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"V Bonifati","year":"2003","unstructured":"Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E et al (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256\u2013259","journal-title":"Science"},{"key":"10_CR10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/BF01728311","volume":"24","author":"J Booij","year":"1997","unstructured":"Booij J, Tissingh G, Winogrodzka A, Boer GJ, Stoof JC, Wolters EC et al (1997) Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson\u2019s disease. Eur J Nucl Med 24:68\u201371","journal-title":"Eur J Nucl Med"},{"key":"10_CR11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"10_CR12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134","journal-title":"Cell Tissue Res"},{"issue":"S1","key":"10_CR13","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1002\/ana.410320721","volume":"32","author":"DB Calne","year":"1992","unstructured":"Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson\u2019s disease. Ann Neurol 32(S1):S125\u2013S127","journal-title":"Ann Neurol"},{"key":"10_CR14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.nbd.2008.11.011","volume":"33","author":"CM Chen","year":"2009","unstructured":"Chen CM, Liu JL, Wu YR, Chen YC, Cheng HS, Cheng ML et al (2009) Increased oxidative damage in peripheral blood correlates with severity of Parkinson\u2019s disease. Neurobiol Dis 33:429\u2013435","journal-title":"Neurobiol Dis"},{"issue":"S1","key":"10_CR15","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1002\/mds.22713","volume":"25","author":"MR Cookson","year":"2010","unstructured":"Cookson MR (2010) DJ-1, PINK1, and their effects on mitochondrial pathways. Mov Disord 25(S1):S44\u2013S48","journal-title":"Mov Disord"},{"key":"10_CR16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2011.11.001","volume":"314","author":"DO Cristalli","year":"2012","unstructured":"Cristalli DO, Arnal N, Marra FA, de Alaniz MJ, Marra CA (2012) Peripheral markers in neurodegenerative patients and their first-degree relatives. J Neurol Sci 314:48\u201356","journal-title":"J Neurol Sci"},{"key":"10_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(93)90175-F","volume":"52","author":"P Damier","year":"1993","unstructured":"Damier P, Hirsch EC, Zhang P, Agid Y, Javoy-Agid F (1993) Glutathione peroxidase, glial cells and Parkinson\u2019s disease. Neuroscience 52:1\u20136","journal-title":"Neuroscience"},{"issue":"Suppl","key":"10_CR18","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1002\/ana.410320716","volume":"32","author":"DT Dexter","year":"1992","unstructured":"Dexter DT, Jenner P, Schapira AH, Marsden CD (1992) Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The royal kings and queens Parkinson\u2019s disease research group. Ann Neurol 32(Suppl):S94\u2013100","journal-title":"Ann Neurol"},{"key":"10_CR19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis 3:461\u2013491","journal-title":"J Parkinsons Dis"},{"key":"10_CR20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00401-008-0345-7","volume":"115","author":"DW Dickson","year":"2008","unstructured":"Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ et al (2008) Evidence that incidental Lewy body disease is pre-symptomatic Parkinson\u2019s disease. Acta Neuropathol 115:437\u2013444","journal-title":"Acta Neuropathol"},{"key":"10_CR21","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060\u20131072","journal-title":"Cell"},{"key":"10_CR22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","volume":"20","author":"OM El-Agnaf","year":"2006","unstructured":"El-Agnaf OM, Salem SA, Paleologou KE, Curran MD, Gibson MJ, Court JA et al (2006) Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease. FASEB J 20:419\u2013425","journal-title":"FASEB J"},{"key":"10_CR23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","volume":"55","author":"LS Forno","year":"1996","unstructured":"Forno LS (1996) Neuropathology of Parkinson\u2019s disease. J Neuropathol Exp Neurol 55:259\u2013272","journal-title":"J Neuropathol Exp Neurol"},{"key":"10_CR24","doi-asserted-by":"crossref","first-page":"37043","DOI":"10.18632\/oncotarget.6158","volume":"6","author":"Y Gui","year":"2015","unstructured":"Gui Y, Liu H, Zhang L, Lv W, Hu X (2015) Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget 6:37043\u201337053","journal-title":"Oncotarget"},{"key":"10_CR25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nature09536","volume":"468","author":"JN Guzman","year":"2010","unstructured":"Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, Schumacker PT et al (2010) Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468:696\u2013700","journal-title":"Nature"},{"key":"10_CR26","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mds.22401","volume":"24","author":"RA Hauser","year":"2009","unstructured":"Hauser RA, Lyons KE, McClain T, Carter S, Perlmutter D (2009) Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson\u2019s disease. Mov Disord 24:979\u2013983","journal-title":"Mov Disord"},{"key":"10_CR27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1126\/science.181.4098.456","volume":"181","author":"RE Heikkila","year":"1973","unstructured":"Heikkila RE, Cohen G (1973) 6-Hydroxydopamine: evidence for superoxide radical as an oxidative intermediate. Science 181:456\u2013457","journal-title":"Science"},{"key":"10_CR28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427\u2013442","journal-title":"Neurology"},{"key":"10_CR29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e31829ae713","volume":"36","author":"MJ Holmay","year":"2013","unstructured":"Holmay MJ, Terpstra M, Coles LD, Mishra U, Ahlskog M, Oz G et al (2013) N-acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases. Clin Neuropharmacol 36:103\u2013106","journal-title":"Clin Neuropharmacol"},{"key":"10_CR30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","volume":"133","author":"Z Hong","year":"2010","unstructured":"Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D et al (2010) DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease. Brain 133:713\u2013726","journal-title":"Brain"},{"key":"10_CR31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10_CR32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1254\/jphs.11151FP","volume":"117","author":"M Inden","year":"2011","unstructured":"Inden M, Kitamura Y, Takahashi K, Takata K, Ito N, Niwa R et al (2011) Protection against dopaminergic neurodegeneration in Parkinson\u2019s disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson\u2019s disease-linked PARK7. J Pharmacol Sci 117:189\u2013203","journal-title":"J Pharmacol Sci"},{"key":"10_CR33","doi-asserted-by":"crossref","first-page":"28832","DOI":"10.1074\/jbc.M109.019950","volume":"284","author":"S Ishikawa","year":"2009","unstructured":"Ishikawa S, Taira T, Niki T, Takahashi-Niki K, Maita C, Maita H et al (2009) Oxidative status of DJ-1-dependent activation of dopamine synthesis through interaction of tyrosine hydroxylase and 4-dihydroxy-L-phenylalanine (L-DOPA) decarboxylase with DJ-1. J Biol Chem 284:28832\u201328844","journal-title":"J Biol Chem"},{"key":"10_CR34","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00403-015-1605-8","volume":"307","author":"S Ishiwatari","year":"2015","unstructured":"Ishiwatari S, Takahashi M, Yasuda C, Nakagawa M, Saito Y, Noguchi N et al (2015) The protective role of DJ-1 in ultraviolet-induced damage of human skin: DJ-1 levels in the stratum corneum as an indicator of antioxidative defense. Arch Dermatol Res 307:925\u2013935","journal-title":"Arch Dermatol Res"},{"key":"10_CR35","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/jnr.20382","volume":"79","author":"Y Izumi","year":"2005","unstructured":"Izumi Y, Sawada H, Sakka N, Yamamoto N, Kume T, Katsuki H et al (2005) P-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly. J Neurosci Res 79:849\u2013860","journal-title":"J Neurosci Res"},{"issue":"S3","key":"10_CR36","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","volume":"53","author":"P Jenner","year":"2003","unstructured":"Jenner P (2003) Oxidative stress in Parkinson\u2019s disease. Ann Neurol 53(S3):S26\u2013S38","journal-title":"Ann Neurol"},{"key":"10_CR37","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/466S11a","volume":"466","author":"R Jones","year":"2010","unstructured":"Jones R (2010) Biomarkers: casting the net wide. Nature 466:S11\u2013S12","journal-title":"Nature"},{"key":"10_CR38","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.freeradbiomed.2009.08.003","volume":"47","author":"PJ Kahle","year":"2009","unstructured":"Kahle PJ, Waak J, Gasser T (2009) DJ-1 and prevention of oxidative stress in Parkinson\u2019s disease and other age-related disorders. Free Radic Biol Med 47:1354\u20131361","journal-title":"Free Radic Biol Med"},{"key":"10_CR39","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1128\/MCB.01350-12","volume":"33","author":"I Kato","year":"2013","unstructured":"Kato I, Maita H, Takahashi-Niki K, Saito Y, Noguchi N, Iguchi-Ariga SM et al (2013) Oxidized DJ-1 inhibits p53 by sequestering p53 from promoters in a DNA-binding affinity-dependent manner. Mol Cell Biol 33:340\u2013359","journal-title":"Mol Cell Biol"},{"key":"10_CR40","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bbrc.2004.03.110","volume":"317","author":"T Kinumi","year":"2004","unstructured":"Kinumi T, Kimata J, Taira T, Ariga H, Niki E (2004) Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem Biophys Res Commun 317:722\u2013728","journal-title":"Biochem Biophys Res Commun"},{"key":"10_CR41","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.20834","volume":"59","author":"JW Langston","year":"2006","unstructured":"Langston JW (2006) The Parkinson\u2019s complex: parkinsonism is just the tip of the iceberg. Ann Neurol 59:591\u2013596","journal-title":"Ann Neurol"},{"key":"10_CR42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neuroscience.2011.08.016","volume":"196","author":"NJ Larsen","year":"2011","unstructured":"Larsen NJ, Ambrosi G, Mullett SJ, Berman SB, Hinkle DA (2011) DJ-1 knock-down impairs astrocyte mitochondrial function. Neuroscience 196:251\u2013264","journal-title":"Neuroscience"},{"issue":"Suppl 1","key":"10_CR43","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/S1353-8020(11)70022-0","volume":"18","author":"S Lesage","year":"2012","unstructured":"Lesage S, Brice A (2012) Role of Mendelian genes in \u201csporadic\u201d Parkinson\u2019s disease. Parkinsonism Relat Disord 18(Suppl 1):S66\u2013S70","journal-title":"Parkinsonism Relat Disord"},{"key":"10_CR44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1385\/JMN:29:3:215","volume":"29","author":"N Lev","year":"2006","unstructured":"Lev N, Roncevic D, Ickowicz D, Melamed E, Offen D (2006) Role of DJ-1 in Parkinson\u2019s disease. J Mol Neurosci 29:215\u2013226","journal-title":"J Mol Neurosci"},{"key":"10_CR45","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/srep00954","volume":"2","author":"X Lin","year":"2012","unstructured":"Lin X, Cook TJ, Zabetian CP, Leverenz JB, Peskind ER, Hu SC et al (2012) DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Sci Rep 2:954","journal-title":"Sci Rep"},{"key":"10_CR46","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","volume":"3","author":"J Lotharius","year":"2002","unstructured":"Lotharius J, Brundin P (2002) Pathogenesis of Parkinson\u2019s disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 3:932\u2013942","journal-title":"Nat Rev Neurosci"},{"key":"10_CR47","first-page":"95","volume":"36","author":"SC Lu","year":"2000","unstructured":"Lu SC (2000) Regulation of glutathione synthesis. Curr Top Cell Regul 36:95\u2013116","journal-title":"Curr Top Cell Regul"},{"key":"10_CR48","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1471-4159.1981.tb01631.x","volume":"36","author":"HS Maker","year":"1981","unstructured":"Maker HS, Weiss C, Silides DJ, Cohen G (1981) Coupling of dopamine oxidation (monoamine oxidase activity) to glutathione oxidation via the generation of hydrogen peroxide in rat brain homogenates. J Neurochem 36:589\u2013593","journal-title":"J Neurochem"},{"key":"10_CR49","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncpneuro0355","volume":"2","author":"NJ Maragakis","year":"2006","unstructured":"Maragakis NJ, Rothstein JD (2006) Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2:679\u2013689","journal-title":"Nat Clin Pract Neurol"},{"key":"10_CR50","volume":"2","author":"KL Mischley","year":"2016","unstructured":"Mischley KL, Conley KE, Shankland EG, Kavanagh TJ, Rosenfeld ME, Duda JE, White CC, Wilbur TK, Torre PU, Padowski JM (2016) Central nervous system uptake of intranasal glutathione in Parkinson\u2019s disease. npj Park Dis 2:16002","journal-title":"npj Park Dis"},{"key":"10_CR51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10715760100300831","volume":"35","author":"A Mitsumoto","year":"2001","unstructured":"Mitsumoto A, Nakagawa Y, Takeuchi A, Okawa K, Iwamatsu A, Takanezawa Y (2001) Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat. Free Radic Res 35:301\u2013310","journal-title":"Free Radic Res"},{"key":"10_CR52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027883","volume":"6","author":"A Miyama","year":"2011","unstructured":"Miyama A, Saito Y, Yamanaka K, Hayashi K, Hamakubo T, Noguchi N (2011) Oxidation of DJ-1 induced by 6-hydroxydopamine decreasing intracellular glutathione. PLoS One 6:e27883","journal-title":"PLoS One"},{"key":"10_CR53","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2217\/bmm.10.90","volume":"4","author":"B Mollenhauer","year":"2010","unstructured":"Mollenhauer B, El-Agnaf OM, Marcus K, Trenkwalder C, Schlossmacher MG (2010) Quantification of alpha-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies. Biomark Med 4:683\u2013699","journal-title":"Biomark Med"},{"key":"10_CR54","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1038\/ncomms7609","volume":"6","author":"O Moscovitz","year":"2015","unstructured":"Moscovitz O, Ben-Nissan G, Fainer I, Pollack D, Mizrachi L, Sharon M (2015) The Parkinson\u2019s-associated protein DJ-1 regulates the 20S proteasome. Nat Commun 6:6609","journal-title":"Nat Commun"},{"key":"10_CR55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1440-1789.2008.00955.x","volume":"29","author":"SJ Mullett","year":"2009","unstructured":"Mullett SJ, Hamilton RL, Hinkle DA (2009) DJ-1 immunoreactivity in human brain astrocytes is dependent on infarct presence and infarct age. Neuropathology 29:125\u2013131","journal-title":"Neuropathology"},{"key":"10_CR56","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12031-012-9904-4","volume":"49","author":"SJ Mullett","year":"2013","unstructured":"Mullett SJ, Di Maio R, Greenamyre JT, Hinkle DA (2013) DJ-1 expression modulates astrocyte-mediated protection against neuronal oxidative stress. J Mol Neurosci 49:507\u2013511","journal-title":"J Mol Neurosci"},{"key":"10_CR57","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00401-004-0834-2","volume":"107","author":"M Neumann","year":"2004","unstructured":"Neumann M, Muller V, Gorner K, Kretzschmar HA, Haass C, Kahle PJ (2004) Pathological properties of the Parkinson\u2019s disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick\u2019s disease. Acta Neuropathol 107:489\u2013496","journal-title":"Acta Neuropathol"},{"key":"10_CR58","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1212\/01.wnl.0000262033.01945.9a","volume":"68","author":"AE Oakley","year":"2007","unstructured":"Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA et al (2007) Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 68:1820\u20131825","journal-title":"Neurology"},{"key":"10_CR59","first-page":"471","volume":"66","author":"I Ogawa","year":"2014","unstructured":"Ogawa I, Saito Y, Saigoh K, Hosoi Y, Mitsui Y, Noguchi N et al (2014) The significance of oxidized DJ-1 protein (oxDJ-1) as a biomarker for Parkinson\u2019s disease. Brain Nerve 66:471\u2013477","journal-title":"Brain Nerve"},{"key":"10_CR60","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","volume":"67","author":"S Orimo","year":"1999","unstructured":"Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H (1999) (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 67:189\u2013194","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10_CR61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1750-3639.2006.00032.x","volume":"17","author":"S Orimo","year":"2007","unstructured":"Orimo S, Takahashi A, Uchihara T, Mori F, Kakita A, Wakabayashi K et al (2007) Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson\u2019s disease. Brain Pathol 17:24\u201330","journal-title":"Brain Pathol"},{"key":"10_CR62","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"Parkinson Progression Marker Initiative","year":"2011","unstructured":"Parkinson Progression Marker Initiative (2011) The Parkinson progression marker initiative (PPMI). Prog Neurobiol 95:629\u2013635","journal-title":"Prog Neurobiol"},{"key":"10_CR63","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2013.10","volume":"9","author":"L Parnetti","year":"2013","unstructured":"Parnetti L, Castrioto A, Chiasserini D, Persichetti E, Tambasco N, El-Agnaf O et al (2013) Cerebrospinal fluid biomarkers in Parkinson disease. Nat Rev Neurol 9:131\u2013140","journal-title":"Nat Rev Neurol"},{"key":"10_CR64","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0304-3940(82)90390-1","volume":"33","author":"TL Perry","year":"1982","unstructured":"Perry TL, Godin DV, Hansen S (1982) Parkinson\u2019s disease: a disorder due to nigral glutathione deficiency? Neurosci Lett 33:305\u2013310","journal-title":"Neurosci Lett"},{"key":"10_CR65","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/jm970099t","volume":"40","author":"A Pezzella","year":"1997","unstructured":"Pezzella A, d\u2019Ischia M, Napolitano A, Misuraca G, Prota G (1997) Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: a possible contributory mechanism for neuronal degeneration in Parkinson\u2019s disease. J Med Chem 40:2211\u20132216","journal-title":"J Med Chem"},{"key":"10_CR66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/mds.870080116","volume":"8","author":"BA Rybicki","year":"1993","unstructured":"Rybicki BA, Johnson CC, Uman J, Gorell JM (1993) Parkinson\u2019s disease mortality and the industrial use of heavy metals in Michigan. Mov Disord 8:87\u201392","journal-title":"Mov Disord"},{"key":"10_CR67","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3164\/jcbn.13-108","volume":"54","author":"Y Saito","year":"2014","unstructured":"Saito Y (2014) Oxidized DJ-1 as a possible biomarker of Parkinson\u2019s disease. J Clin Biochem Nutr 54:138\u2013144","journal-title":"J Clin Biochem Nutr"},{"key":"10_CR68","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnen\/63.7.742","volume":"63","author":"Y Saito","year":"2004","unstructured":"Saito Y, Ruberu NN, Sawabe M, Arai T, Kazama H, Hosoi T et al (2004) Lewy body-related alpha-synucleinopathy in aging. J Neuropathol Exp Neurol 63:742\u2013749","journal-title":"J Neuropathol Exp Neurol"},{"key":"10_CR69","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/10715760600632552","volume":"40","author":"Y Saito","year":"2006","unstructured":"Saito Y, Nishio K, Ogawa Y, Kimata J, Kinumi T, Yoshida Y et al (2006) Turning point in apoptosis\/necrosis induced by hydrogen peroxide. Free Radic Res 40:619\u2013630","journal-title":"Free Radic Res"},{"key":"10_CR70","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.freeradbiomed.2006.12.004","volume":"42","author":"Y Saito","year":"2007","unstructured":"Saito Y, Nishio K, Ogawa Y, Kinumi T, Yoshida Y, Masuo Y et al (2007a) Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action. Free Radic Biol Med 42:675\u2013685","journal-title":"Free Radic Biol Med"},{"key":"10_CR71","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/j.1471-4159.2007.04701.x","volume":"102","author":"Y Saito","year":"2007","unstructured":"Saito Y, Nishio K, Numakawa Y, Ogawa Y, Yoshida Y, Noguchi N et al (2007b) Protective effects of 15-deoxy-Delta12,14-prostaglandin J2 against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione. J Neurochem 102:1625\u20131634","journal-title":"J Neurochem"},{"key":"10_CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2009.08.074","volume":"465","author":"Y Saito","year":"2009","unstructured":"Saito Y, Hamakubo T, Yoshida Y, Ogawa Y, Hara Y, Fujimura H et al (2009) Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients. Neurosci Lett 465:1\u20135","journal-title":"Neurosci Lett"},{"key":"10_CR73","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/NEN.0000000000000087","volume":"73","author":"Y Saito","year":"2014","unstructured":"Saito Y, Miyasaka T, Hatsuta H, Takahashi-Niki K, Hayashi K, Mita Y et al (2014) Immunostaining of oxidized DJ-1 in human and mouse brains. J Neuropathol Exp Neurol 73:714\u2013728","journal-title":"J Neuropathol Exp Neurol"},{"key":"10_CR74","volume":"6","author":"Y Saito","year":"2016","unstructured":"Saito Y, Akazawa-Ogawa Y, Matsumura A, Saigoh K, Itoh S, Sutou K et al (2016) Oxidation and interaction of DJ-1 with 20S proteasome in the erythrocytes of early stage Parkinson\u2019s disease patients. Sci Rep 6:30793","journal-title":"Sci Rep"},{"key":"10_CR75","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.parkreldis.2012.03.013","volume":"18","author":"L Salvesen","year":"2012","unstructured":"Salvesen L, Bech S, Lokkegaard A, Hjermind LE, Nielsen JE, Pakkenberg B et al (2012) The DJ-1 concentration in cerebrospinal fluid does not differentiate among Parkinsonian syndromes. Parkinsonism Relat Disord 18:899\u2013901","journal-title":"Parkinsonism Relat Disord"},{"key":"10_CR76","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1021\/tx700210j","volume":"21","author":"LM Sayre","year":"2008","unstructured":"Sayre LM, Perry G, Smith MA (2008) Oxidative stress and neurotoxicity. Chem Res Toxicol 21:172\u2013188","journal-title":"Chem Res Toxicol"},{"key":"10_CR77","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/WCO.0b013e3283633741","volume":"26","author":"AH Schapira","year":"2013","unstructured":"Schapira AH (2013) Recent developments in biomarkers in Parkinson disease. Curr Opin Neurol 26:395\u2013400","journal-title":"Curr Opin Neurol"},{"key":"10_CR78","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0278-5846(96)00103-0","volume":"20","author":"G Sechi","year":"1996","unstructured":"Sechi G, Deledda MG, Bua G, Satta WM, Deiana GA, Pes GM et al (1996) Reduced intravenous glutathione in the treatment of early Parkinson\u2019s disease. Prog Neuro-Psychopharmacol Biol Psychiatry 20:1159\u20131170","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10_CR79","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1212\/WNL.42.7.1328","volume":"42","author":"KM Semchuk","year":"1992","unstructured":"Semchuk KM, Love EJ, Lee RG (1992) Parkinson\u2019s disease and exposure to agricultural work and pesticide chemicals. Neurology 42:1328\u20131335","journal-title":"Neurology"},{"key":"10_CR80","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuint.2013.06.005","volume":"63","author":"S Sharma","year":"2013","unstructured":"Sharma S, Moon CS, Khogali A, Haidous A, Chabenne A, Ojo C et al (2013) Biomarkers in Parkinson\u2019s disease (recent update). Neurochem Int 63:201\u2013229","journal-title":"Neurochem Int"},{"key":"10_CR81","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2010.06.009","volume":"480","author":"M Shi","year":"2010","unstructured":"Shi M, Zabetian CP, Hancock AM, Ginghina C, Hong Z, Yearout D et al (2010) Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson\u2019s disease. Neurosci Lett 480:78\u201382","journal-title":"Neurosci Lett"},{"key":"10_CR82","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.22311","volume":"69","author":"M Shi","year":"2011","unstructured":"Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER et al (2011) Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol 69:570\u2013580","journal-title":"Ann Neurol"},{"key":"10_CR83","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","volume":"36","author":"J Sian","year":"1994","unstructured":"Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F et al (1994) Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36:348\u2013355","journal-title":"Ann Neurol"},{"key":"10_CR84","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0891-5849(99)00177-X","volume":"27","author":"H Sies","year":"1999","unstructured":"Sies H (1999) Glutathione and its role in cellular functions. Free Radic Biol Med 27:916\u2013921","journal-title":"Free Radic Biol Med"},{"key":"10_CR85","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.embor.7400074","volume":"5","author":"T Taira","year":"2004","unstructured":"Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, Ariga H (2004) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5:213\u2013218","journal-title":"EMBO Rep"},{"key":"10_CR86","doi-asserted-by":"crossref","first-page":"41254","DOI":"10.1074\/jbc.M202773200","volume":"277","author":"G Takebe","year":"2002","unstructured":"Takebe G, Yarimizu J, Saito Y, Hayashi T, Nakamura H, Yodoi J et\u00a0al (2002) A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P. J Biol Chem 277:41254\u201341258","journal-title":"J Biol Chem"},{"key":"10_CR87","doi-asserted-by":"crossref","first-page":"10244","DOI":"10.1073\/pnas.0708518105","volume":"105","author":"MP Brug van der","year":"2008","unstructured":"van der Brug MP, Blackinton J, Chandran J, Hao LY, Lal A, Mazan-Mamczarz K et al (2008) RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. Proc Natl Acad Sci U S A 105:10244\u201310249","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR88","first-page":"12","volume":"2","author":"X Wang","year":"2010","unstructured":"Wang X, Michaelis EK (2010) Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci 2:12","journal-title":"Front Aging Neurosci"},{"key":"10_CR89","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1073\/pnas.0510962103","volume":"103","author":"X Wang","year":"2006","unstructured":"Wang X, Thomas B, Sachdeva R, Arterburn L, Frye L, Hatcher PG et al (2006) Mechanism of arylating quinone toxicity involving Michael adduct formation and induction of endoplasmic reticulum stress. Proc Natl Acad Sci U S A 103:3604\u20133609","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR90","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neulet.2015.05.030","volume":"599","author":"X Wang","year":"2015","unstructured":"Wang X, Yu S, Li F, Feng T (2015) Detection of alpha-synuclein oligomers in red blood cells as a potential biomarker of Parkinson\u2019s disease. Neurosci Lett 599:115\u2013119","journal-title":"Neurosci Lett"},{"key":"10_CR91","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2007.08.010","volume":"425","author":"M Waragai","year":"2007","unstructured":"Waragai M, Nakai M, Wei J, Fujita M, Mizuno H, Ho G et al (2007) Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson\u2019s disease. Neurosci Lett 425:18\u201322","journal-title":"Neurosci Lett"},{"key":"10_CR92","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/ars.2010.3481","volume":"15","author":"MA Wilson","year":"2011","unstructured":"Wilson MA (2011) The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxid Redox Signal 15:111\u2013122","journal-title":"Antioxid Redox Signal"},{"key":"10_CR93","doi-asserted-by":"crossref","first-page":"7430","DOI":"10.1021\/bi800282d","volume":"47","author":"AC Witt","year":"2008","unstructured":"Witt AC, Lakshminarasimhan M, Remington BC, Hasim S, Pozharski E, Wilson MA (2008) Cysteine pKa depression by a protonated glutamic acid in human DJ-1. Biochemistry 47:7430\u20137440","journal-title":"Biochemistry"},{"key":"10_CR94","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2016.01.029","volume":"615","author":"N Yalcinkaya","year":"2016","unstructured":"Yalcinkaya N, Haytural H, Bilgic B, Ozdemir O, Hanagasi H, Kucukali CI et al (2016) Expression changes of genes associated with apoptosis and survival processes in Parkinson\u2019s disease. Neurosci Lett 615:72\u201377","journal-title":"Neurosci Lett"},{"key":"10_CR95","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4161\/oxim.2.1.7985","volume":"2","author":"T Yanagida","year":"2009","unstructured":"Yanagida T, Tsushima J, Kitamura Y, Yanagisawa D, Takata K, Shibaike T et al (2009) Oxidative stress induction of DJ-1 protein in reactive astrocytes scavenges free radicals and reduces cell injury. Oxidative Med Cell Longev 2:36\u201342","journal-title":"Oxidative Med Cell Longev"},{"key":"10_CR96","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156:317\u2013331","journal-title":"Cell"},{"key":"10_CR97","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tins.2003.08.009","volume":"26","author":"L Zecca","year":"2003","unstructured":"Zecca L, Zucca FA, Wilms H, Sulzer D (2003) Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics. Trends Neurosci 26:578\u2013580","journal-title":"Trends Neurosci"},{"key":"10_CR98","doi-asserted-by":"crossref","first-page":"20940","DOI":"10.1074\/jbc.M601935200","volume":"281","author":"N Zhong","year":"2006","unstructured":"Zhong N, Kim CY, Rizzu P, Geula C, Porter DR, Pothos EN et al (2006) DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor. J Biol Chem 281:20940\u201320948","journal-title":"J Biol Chem"},{"key":"10_CR99","doi-asserted-by":"crossref","first-page":"43150","DOI":"10.1074\/jbc.M507124200","volume":"280","author":"W Zhou","year":"2005","unstructured":"Zhou W, Freed CR (2005) DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. J Biol Chem 280:43150\u201343158","journal-title":"J Biol Chem"},{"key":"10_CR100","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jmb.2005.12.030","volume":"356","author":"W Zhou","year":"2006","unstructured":"Zhou W, Zhu M, Wilson MA, Petsko GA, Fink AL (2006) The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J Mol Biol 356:1036\u20131048","journal-title":"J Mol Biol"}],"container-title":["Advances in Experimental Medicine and Biology","DJ-1\/PARK7 Protein"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-6583-5_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T23:27:23Z","timestamp":1603322843000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-6583-5_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9789811065828","9789811065835"],"references-count":100,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-6583-5_10","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}